RLFTD Stock Price, News & Analysis
RLFTD
Company Description
Relief Therapeutics Holding SA (RLFTD), a biopharmaceutical company, focuses on providing innovative treatment options for select specialty and rare diseases. The company is committed to delivering transformative outcomes to benefit patients suffering from various conditions. Relief Therapeutics' portfolio includes revenue-generating products, proprietary drug delivery platform technologies, and a clinical development pipeline targeting rare metabolic, dermatology, and respiratory diseases. Recently, the company announced exclusive distribution agreements, financial results, and corporate updates.
Stock Performance
$—
0.00%
0.00
Last updated:
- %
Performance 1 year
$44.9M
Market Cap
11.0M
Shares outstanding
Latest News
SEC Filings
No SEC filings available for RLFTD.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin
Upcoming Events
Frequently Asked Questions
What is the market cap of RLFTD (RLFTD)?
The market cap of RLFTD (RLFTD) is approximately 44.9M.
What is Relief Therapeutics?
Relief Therapeutics is a biopharmaceutical company focused on providing innovative treatment options for select specialty and rare diseases.
What does Relief Therapeutics offer in its portfolio?
Relief Therapeutics' portfolio includes revenue-generating products, proprietary drug delivery platform technologies, and a clinical development pipeline targeting rare metabolic, dermatology, and respiratory diseases.
What recent announcements has Relief Therapeutics made?
Relief Therapeutics recently announced exclusive distribution agreements, financial results, and corporate updates.